Lataa...
SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas
BACKGROUND: Gliomas are one of the most common primary tumors of the central nervous system, and have an unfavorable prognosis. SLC39A1 is a zinc ion transport protein which inhibits the progression of prostate cancer. By studying the role and mechanism of SLC39A1 in the progression of gliomas, perh...
Tallennettuna:
| Julkaisussa: | Cancer Cell Int |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7694905/ https://ncbi.nlm.nih.gov/pubmed/33292262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-01675-0 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|